Our expert says:
Hi Dave - all I have is this response form Adcock (seems like it will be back):
"Adcock Ingram, together with MSD (pharmaceutical company known as Merck in the US), is not in a position to supply a number of women’s health products (including Livifem) until further notice. Any of these products currently in the marketplace can continue to be used.
We have stopped supply of these women’s health products because of a number of aspects relating to product-related documentation which have to be updated to comply with global requirements. This documentation is currently being updated in conjunction with regulatory authorities.
These requirements include but are not limited to:
* Changes in labelling and packaging.
* Quality control and assurance of existing product.
* Consistency with global company standards.
The supply of these products, including Livifem, can be resumed only once the regulatory updates have been approved by the local regulatory authorities. These timelines could differ depending on the various products.
Communication has been sent out to the health-care professionals informing them of this gap.
We would like to assure you that this decision has been made with due consideration of the medical need for Livifem, and all the other affected women’s health products.
Please note that there is no impact on the quality or safety of the products currently in use by patients. Alternative therapies have been discussed with doctors. We advise patients to contact their doctor who will advise on an alternative medication.
We regret any inconvenience which may be caused as a result of the out-of-stock situation."
External communications manager,
The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal
advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.